Medication info
Nexocan Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Nexocan Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›43.38mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu * 2)
Approval status
Active

MFDS item code 201801828 · Approved 2018.04.30 · Insurance code 665002480

Summary

Main use
Treatment of acid-related disorders (reflux, ulcers, etc.), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control subsequent symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. Combination therapy with antibiotics for Helicobacter pylori eradication: Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors): 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. Patients requiring continued treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome: The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into two doses. Maintenance therapy following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers: Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue for an additional 4 weeks. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administering this medicine to children under 12 years of age.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (reflux, ulcers, etc.), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease and erosive reflux esophagitis as well as for long-term maintenance therapy for the prevention of recurrence in patients with esophagitis. It is also effective for the treatment of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection when used in combination with antibiotics. Additionally, it helps treat and prevent upper gastrointestinal symptoms and gastric ulcers caused by taking nonsteroidal anti-inflammatory drugs. It is also used in the treatment of Zollinger-Ellison syndrome and is suitable for maintenance therapy after preventing rebleeding from gastric ulcers or duodenal ulcers. It is widely used for the treatment and prevention of various gastrointestinal diseases.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control subsequent symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. Combination therapy with antibiotics for Helicobacter pylori eradication: Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors): 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. Patients requiring continued treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome: The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into two doses. Maintenance therapy following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers: Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue for an additional 4 weeks. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administering this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. For example, patients who are allergic to this medication or its components, patients with hypersensitivity to certain antibiotics, and those with a history of certain heart diseases should avoid taking it. Moreover, breastfeeding women should not take this medication. This medication can cause various side effects, so if any abnormal symptoms occur during use, one should immediately consult a doctor. Symptoms such as headache, abdominal pain, diarrhea, skin rash, muscle pain, etc., have been reported, and in rare cases, serious skin reactions or hematological abnormalities may also occur. Regular check-ups are needed for prolonged use of this medication. In particular, if used for more than one year, magnesium levels and fracture risks should be carefully monitored. This medication suppresses stomach acid secretion, which may change the gastric environment and increase the risk of certain bacterial infections. Moreover, there is a high possibility of interaction with other medications, so you must inform your doctor or pharmacist if you are taking any other medications. Special caution is required when combined with drugs that affect blood coagulation, antiviral drugs, and antibiotics. Its safety during pregnancy has not been sufficiently established, thus it should be used cautiously, and it is advisable to avoid taking it during breastfeeding. There is no specific antidote for overdose, so treatment should be symptomatic, and it should be stored out of reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurry vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions associated with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal developmental disorders, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, aggravation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonicity, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, dizziness, visual field defects, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, dysosmia, ageusia, parageusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric adenomatous polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.